We are live on ! Find out more
KURA icon

Kura Oncology
KURA

116 hedge funds and large institutions have $610M invested in Kura Oncology in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $40K | Put options by funds: $18K

71% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 31

1.25% more ownership

Funds ownership: 87.74% → 88.99% (+1.3%)

5% less funds holding

Funds holding: 122 → 116 (-6)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

20% less capital invested

Capital invested by funds: $762M → $610M (-$151M)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
116
Holders Change
-6
Holders Change %
-4.92%
% of All Funds
2.54%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
10
Increased
53
Reduced
31
Closed
16
Calls
$40K
Puts
$18K
Net Calls
+$22K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$33.1M
2
BlackRock
BlackRock
New York
+$10.1M
3
State Street
State Street
Massachusetts
+$7.47M
4
Victory Capital Management
Victory Capital Management
Texas
+$5.33M
5
N
Nuveen
North Carolina
+$5.1M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$22M
2
AVM
Arch Venture Management
Illinois
-$8.01M
3
FI
Fosun International
China
-$7.34M
4
Marshall Wace
Marshall Wace
United Kingdom
-$5.51M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$3.33M +$3.86M +217,082 +9,015%
Goldman Sachs
27
Goldman Sachs
New York
$3.29M -$19.2K -1,077 -0.5%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$2.97M +$2.03M +113,894 +139%
BG
29
Bellevue Group
Switzerland
$2.52M +$376K +21,100 +15%
CAM
30
ClariVest Asset Management
California
$2.17M +$2.07M +116,273 +435%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.14M +$346K +19,436 +16%
CS
32
Candriam SCA
Luxembourg
$2.1M -$3.99M -224,000 -62%
OAM
33
Oxford Asset Management
United Kingdom
$1.81M -$728K -40,904 -26%
CIA
34
Capital Impact Advisors
Massachusetts
$1.8M +$357K +20,075 +20%
KCM
35
Kennedy Capital Management
Missouri
$1.74M -$127K -7,143 -6%
SG Americas Securities
36
SG Americas Securities
New York
$1.57M +$1.72M +96,885 +1,393%
DCM
37
DAFNA Capital Management
California
$1.57M +$1M +56,416 +119%
Bank of America
38
Bank of America
North Carolina
$1.5M -$361K -20,277 -17%
ACP
39
Acuta Capital Partners
California
$1.44M +$1.69M +95,000 New
AA
40
ALPS Advisors
Colorado
$1.37M +$181K +10,184 +13%
AGA
41
Altrinsic Global Advisors
Connecticut
$1.36M -$89K -5,000 -5%
MA
42
Minerva Advisors
Pennsylvania
$1.31M -$40.8K -2,292 -3%
Squarepoint
43
Squarepoint
New York
$1.25M +$1.03M +57,615 +233%
UBS Group
44
UBS Group
Switzerland
$1.19M +$1.37M +76,917 +4,390%
CCP
45
Clough Capital Partners
Massachusetts
$1.1M -$67.6K -3,800 -5%
Deutsche Bank
46
Deutsche Bank
Germany
$1.09M -$96.1K -5,401 -7%
Prudential Financial
47
Prudential Financial
New Jersey
$1.01M +$1.19M +66,622 New
Two Sigma Investments
48
Two Sigma Investments
New York
$966K -$414K -23,256 -27%
Swiss National Bank
49
Swiss National Bank
Switzerland
$931K – – –
Rafferty Asset Management
50
Rafferty Asset Management
New York
$908K +$684K +38,409 +179%
1
2
3 4 5

KURA Hedge Fund Activity: Q3 2019 in Review

116 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2019, worth a combined $610M — down 20% from $762M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of KURA and 10 opened new positions — a net loss of 6 holders — while 31 trimmed existing stakes and 53 added.

The largest buyer was Fidelity Investments, adding an estimated $33.1M. The largest seller was EcoR1 Capital, cutting an estimated $22M.

  • 116 institutional investors held Kura Oncology (KURA) as of Q3 2019, down from 122 in Q2 2019.
  • Funds reported $610M of Kura Oncology stock for Q3 2019, down 20% quarter-over-quarter.
  • 10 funds opened new Kura Oncology positions in Q3 2019 and 16 closed out, a net change of -6 holders.
  • The largest Kura Oncology buyer in Q3 2019 was Fidelity Investments, an estimated $33.1M added.
  • The largest Kura Oncology seller in Q3 2019 was EcoR1 Capital, an estimated $22M sold.

Based on aggregated 13F filings for Q3 2019.